(Q36943145)

English

Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: Case reports and review of crisis management

scientific article published on November 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: case reports and review of crisis management (English)

1 reference

Europe PubMed Central

17 August 2017

Emergency department analgesia without narcotics for adults with acute sickle cell pain crisis: Case reports and review of crisis management (English)

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

sickle-cell disease

0 references

pain management

0 references

emergency medicine

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

author name string

Pollack CV Jr

1

1 reference

Europe PubMed Central

17 August 2017

Severance HW Jr

3

1 reference

Europe PubMed Central

17 August 2017

C. V. Pollack

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1787291

23 November 2022

D. Y. Sanders

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1787291

23 November 2022

H. W. Severance

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1787291

23 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1787291

23 November 2022

publication date

1 November 1991

1 reference

Europe PubMed Central

17 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0736467991902163?httpAccept=text/xml

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

https://api.elsevier.com/content/article/PII:0736467991902163?httpAccept=text/plain

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Journal of Emergency Medicine

1 reference

Europe PubMed Central

17 August 2017

9

1 reference

Europe PubMed Central

17 August 2017

6

1 reference

Europe PubMed Central

17 August 2017

445-452

1 reference

Europe PubMed Central

17 August 2017

PECULIAR ELONGATED AND SICKLE-SHAPED RED BLOOD CORPUSCLES IN A CASE OF SEVERE ANEMIA

1

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle cell disease

3

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts).

5

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Treatment of pain in adults with sickle cell disease

6

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Oral analgesia for treatment of painful crisis in sickle cell anemia

8

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle-cell anemia--a review

9

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Management of sickle cell disease

10

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle cell crisis precipitated by periodontal infection: report of two cases

11

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Frequency of pain crisis during pregnancy

16

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Pneumonia and pulmonary infarction in sickle cell anemia.

18

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Usefulness of empiric chest radiography and urinalysis testing in adults with acute sickle cell pain crisis

19

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Pulmonary edema. Complication in the management of sickle cell pain crisis

20

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia

23

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Oxygen therapy in sickle-cell anemia

24

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Pain management in sickle cell disease. Rationale and techniques

25

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

The management of pain in sickle cell disease

26

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Clinical studies of a continuous extracorporeal cyanate treatment system for patients with sickle cell disease

27

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Preliminary studies of continuous extracorporeal carbamylation in the treatment of sickle cell anemia

28

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Urea and Sickling

29

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Long-term anti-coagulation in sickle-cell disease. A clinical study

30

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Trial of low doses of aspirin as prophylaxis in sickle cell disease

33

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients

35

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Serum concentrations of meperidine in patients with sickle cell crisis

37

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Central nervous system excitatory effects of meperidine in cancer patients

38

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Meperidine usage in patients with sickle cell crisis

39

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Constant morphine infusion for severe sickle cell crisis pain

41

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Patient-controlled analgesia in patients with sickle cell vaso-occlusive crisis

43

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Intravenous narcotics in sickle cell crises

44

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Management protocol for sickle-cell disease patients with acute pain: impact on emergency department and narcotic use.

45

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle-cell anemia crisis; report on seven patients treated with priscoline

47

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Treatment of painful sickle cell crises with papaverine: preliminary report

48

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

TREATMENT OF PAINFUL CRISES OF SICKLE CELL DISEASE. A DOUBLE BLIND STUDY

51

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Efficacy of oral zinc therapy in the management of sickle cell crises

52

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Acupuncture: An evaluation in the painful crises of sickle cell anaemia

53

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

The effectiveness of biofeedback-assisted relaxation in modifying sickle cell crises

54

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises

55

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Hypnotically induced pain control in sickle cell anemia

56

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Comparison of intramuscular ketorolac and morphine in pain control after laparotomy

57

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain

58

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Comparison of intramuscular ketorolac tromethamine and morphine sulfate for analgesia of pain after major surgery

59

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Antidepressants in the management of chronic pain syndromes

60

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

61

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone.

62

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Hematologic studies on patients with sickle cell anemia following multiple transfusions

66

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle-cell disease: new method of treatment; preliminary report.

67

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Failure of promazine HCl to prevent the painful episodes in sickle cell anemia

68

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Steroid hormones in sickle-cell disease.

69

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Studies on the interaction of zinc with human hemoglobin.

70

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Restoration of the deformability of "irreversibly" sickled cells by procaine hydrochloride

71

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sodium cyanate as a potential treatment for sickle-cell disease

72

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

A Study of Induced Hyponatremia in the Prevention and Treatment of Sickle-Cell Crisis

75

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea

77

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea

79

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Advances in the understanding of sickle cell anemia

80

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Treatment of sickle-cell anemia.

82

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle cell anemia

83

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sickle cell crisis terminated by intravenous urea in sugar solutions—a preliminary report

84

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Sodium Citrate Orally for Painful Sickle Cell Crises

85

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Ancrod in sickle-cell crisis.

86

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Nalbuphine vs. meperidine in sickle cell anemia

88

1 reference

10.1016/0736-4679(91)90216-3

https://api.crossref.org/works/10.1016/0736-4679(91)90216-3

23 November 2022

Identifiers

10.1016/0736-4679(91)90216-3

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36943145&oldid=1777496331"